Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46884
Title: | Telemedicine: Benefits for Cardiovascular Patients in the COVID-19 Era | Authors: | Ghilencea, Liviu-Nicolae Chiru, Maria-Roxana Stolcova, Miroslava Spiridon, Gabriel Manea, Laura-Maria Stanescu, Ana-Maria Alexandra Bokhari, Awais Kilic, Ismail Dogu Secco, Gioel Gabriel Foin, Nicolas Di Mario, Carlo |
Keywords: | telemedicine telemonitoring COVID-19 cardiovascular disease implantable devices heart failure systemic hypertension and arrhythmia SWOT analysis Heart-Failure Patients Pulmonary-Artery Pressure Atrial-Fibrillation Disease Management Stroke Mortality Efficacy Impact Care Telecardiology |
Publisher: | Frontiers Media Sa | Abstract: | The recent pandemic with SARS-CoV-2 raises questions worldwide regarding telemedicine for housebound patients, including those with cardiovascular conditions. The need for further investigation, monitoring and therapeutic management are advancing practical issues which had not been identified for consideration prior to the pandemic. Using the marketing assessment, we identified the needs of the patients and evaluated the future steps necessary in the short term to meet them. The research found progress made via telemedicine in monitoring and conducting minor decisions (like up-titrating the doses of different medication regimens) in patients with several cardiovascular diseases (heart failure, atrial fibrillation, high blood pressure), as there is a worldwide trend to develop new telemonitoring biosensors and devices based on implantable delivered transcatheter. The worldwide telemedicine trend encourages a switch from small and hesitating steps to a more consistent assessment of the patients, based on high technology and Interventional Cardiology. Cardiovascular telemedicine, although made a sustainable effort in managing patients' health, has many obstacles to overcome before meeting all their needs. Data security, confidentiality and reimbursement are the top priorities in developing remote Cardiology. The regulatory institutions need to play an integrative role in leading the way for defining the framework of future telemedicine activities. The SARS-CoV-2 outbreak with all its tragedy served to reinforce the message that telemedicine services can be life-saving for cardiovascular patients. Once the Covid-19 era will fade away, telemedicine is likely to remain a complementary service of standard care. There is still room to improve the remote identification and investigation of heart disease, provide an accurate diagnosis and therapeutic regimen, and update regulations and guidelines to the new realities of technological progress in the field. | URI: | https://doi.org/10.3389/fcvm.2022.868635 https://hdl.handle.net/11499/46884 |
ISSN: | 2297-055X |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
fcvm-09-868635.pdf | 864.08 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
9
checked on Dec 14, 2024
WEB OF SCIENCETM
Citations
10
checked on Dec 20, 2024
Page view(s)
26
checked on Aug 24, 2024
Download(s)
12
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.